Bioerodible endoprosthesis with biostable inorganic layers

(19)

(11)

EP 2 210 625 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	29.02.2012 Bulletin 2012/09

(45)	Mention of the grant of the patent:
	20.07.2011 Bulletin 2011/29

(21)	Application number: 10159664.1

(22)	Date of filing: 14.09.2007

(51)

International Patent Classification (IPC):

A61L 31/08^(2006.01)

(54)	Bioerodible endoprosthesis with biostable inorganic layers Biologisch erodierbare Endoprothese mit biostabilen anorganischen Schichten Endoprothèse bio-érodable dotée de couches inorganiques biostables

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30)

Priority:

15.09.2006 US 845135 P

(43)	Date of publication of application:
	28.07.2010 Bulletin 2010/30

(60)	Divisional application:
	11174306.8 / 2399616

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	07842485.0 / 2121068

(73)	Proprietor: Boston Scientific Scimed, Inc.
	Christ Church, Barbados, West Indies (BB)

(72)	Inventors:
	Weber, Jan 6228, GJ Maastricht (NL) Atanasoska, Liliana Edina, MN 55436 (US) Schewe, Scott R. Eden Prairie, MN 55346-1334 (US)

(74)	Representative: Peterreins, Frank
	Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Strasse 8 80807 München 80807 München (DE)

(56)

References cited: :

EP-A2- 1 752 167
US-A1- 2004 039 438
US-B1- 6 245 104

WO-A2-01/80920
US-A1- 2005 159 805

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).